Summary GlaxoSmithKline Biologicals SA (Gsk-bio), a subsidiary of GlaxoSmithKline Plc is a healthcare company that research, develops and produces human vaccines. The company develops and enhances vaccines for a range of diseases, which include HIV, influenza, malaria, avian flu and tuberculosis, among others. It offers a range of prescription medicines, vaccines available on prescription and nonprescription care products. Gsk-bio has several approved vaccines for marketing and several others in pipeline. The company has manufacturing facilities in several parts of the world. It partners with WHO and UNICEF to extend its reach to poorer regions and eliminate diseases. Gsk-bio is headquartered in Rixensart, Belgium. GlaxoSmithKline Biologicals SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their... Research Beam Model: Research Beam Product ID: 1238527 250 USD New
GlaxoSmithKline Biologicals SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

GlaxoSmithKline Biologicals SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : March   2017
  • Pages : 18
  • Publisher : GlobalData
 
 
 
Summary

GlaxoSmithKline Biologicals SA (Gsk-bio), a subsidiary of GlaxoSmithKline Plc is a healthcare company that research, develops and produces human vaccines. The company develops and enhances vaccines for a range of diseases, which include HIV, influenza, malaria, avian flu and tuberculosis, among others. It offers a range of prescription medicines, vaccines available on prescription and nonprescription care products. Gsk-bio has several approved vaccines for marketing and several others in pipeline. The company has manufacturing facilities in several parts of the world. It partners with WHO and UNICEF to extend its reach to poorer regions and eliminate diseases. Gsk-bio is headquartered in Rixensart, Belgium.

GlaxoSmithKline Biologicals SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GlaxoSmithKline Biologicals SA, Medical Devices Deals, 2011 to YTD 2017 9
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
VBI Vaccines Enters into Research Agreement with GlaxoSmithKline Biologicals 11
GlycoVaxyn Enters Into Co-Development Agreement With GlaxoSmithKline For Bacterial Vaccines 11
Aeras Enters Into R&D Agreement With GlaxoSmithKline Vaccines To Develop Tuberculosis Vaccine 12
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals 13
GlaxoSmithKline Biologicals SA - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables
List of Tables
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Key Facts 1
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GlaxoSmithKline Biologicals SA, Deals By Therapy Area, 2011 to YTD 2017 8
GlaxoSmithKline Biologicals SA, Medical Devices Deals, 2011 to YTD 2017 9
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
VBI Vaccines Enters into Research Agreement with GlaxoSmithKline Biologicals 11
GlycoVaxyn Enters Into Co-Development Agreement With GlaxoSmithKline For Bacterial Vaccines 11
Aeras Enters Into R&D Agreement With GlaxoSmithKline Vaccines To Develop Tuberculosis Vaccine 12
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals 13
GlaxoSmithKline Biologicals SA, Key Competitors 15
GlaxoSmithKline Biologicals SA, Key Employees 16
GlaxoSmithKline Biologicals SA, Subsidiaries 17

List Of Figures
List of Figures
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GlaxoSmithKline Biologicals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GlaxoSmithKline Biologicals SA, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter